fbpx

Mayne Pharma Group Ltd

MYX.AX

$3.33

Closing

▲0.19%

1D

▼-16.10%

YTD

MYX

BBG001SDB363

Exchange

Sector

Market cap

$266.35M

Volume

163,619

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$266.35M

Analysts' Rating

BUY

Price Target (Mean)

4.14

Total Analysts

1

P/E

Operating Margin

-56.63%

Beta

1.13

Revenue Growth

135.35%

52 week high

$4.81

52 week low

$2.41

Div. Yield

%

EPS Growth

55.19

Company Profile

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company’s products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.